[
  {
    "ts": null,
    "headline": "Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down",
    "summary": "SOLV's Q4 earnings and revenues beat estimates, driven by organic growth across MedSurg, Dental and HIS, despite margins declined.",
    "url": "https://finnhub.io/api/news?id=805fbceb88f03a25a6aa75f6501c79d05680fb65eb56599bc3f8dbb178dc284c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772214300,
      "headline": "Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down",
      "id": 139255736,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "SOLV's Q4 earnings and revenues beat estimates, driven by organic growth across MedSurg, Dental and HIS, despite margins declined.",
      "url": "https://finnhub.io/api/news?id=805fbceb88f03a25a6aa75f6501c79d05680fb65eb56599bc3f8dbb178dc284c"
    }
  },
  {
    "ts": null,
    "headline": "CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash",
    "summary": "Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.",
    "url": "https://finnhub.io/api/news?id=dced7b6fdae6b5a84fd91454a376e7b59c4761bf95468a75392a3417c6f06e44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772213880,
      "headline": "CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash",
      "id": 139255787,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus.",
      "url": "https://finnhub.io/api/news?id=dced7b6fdae6b5a84fd91454a376e7b59c4761bf95468a75392a3417c6f06e44"
    }
  },
  {
    "ts": null,
    "headline": "GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery",
    "summary": "GE HealthCare inks a 10-year Care Alliance with UCSF Health to expand advanced imaging, boost MR excellence and strengthen long-term revenue visibility.",
    "url": "https://finnhub.io/api/news?id=4fc456a6019e9b70718007309b9d3357ac29c4d9a2e32fd609fe6d26a742d713",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772213820,
      "headline": "GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery",
      "id": 139255788,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GE HealthCare inks a 10-year Care Alliance with UCSF Health to expand advanced imaging, boost MR excellence and strengthen long-term revenue visibility.",
      "url": "https://finnhub.io/api/news?id=4fc456a6019e9b70718007309b9d3357ac29c4d9a2e32fd609fe6d26a742d713"
    }
  },
  {
    "ts": null,
    "headline": "TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market",
    "summary": "Teleflex Q4 earnings and revenues miss estimates as margins shrink, but shares rise 1.7% after hours amid 2026 growth guidance and portfolio reshuffle.",
    "url": "https://finnhub.io/api/news?id=98a8f8b89fa033282c67245ba57fdadb9e5132de04e1db9a5a212c4a684bea92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772196120,
      "headline": "TFX Q4 Earnings & Revenues Miss, Margins Down, Stock Up in After-Market",
      "id": 139250156,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Teleflex Q4 earnings and revenues miss estimates as margins shrink, but shares rise 1.7% after hours amid 2026 growth guidance and portfolio reshuffle.",
      "url": "https://finnhub.io/api/news?id=98a8f8b89fa033282c67245ba57fdadb9e5132de04e1db9a5a212c4a684bea92"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For March 2026",
    "summary": "NOBL is up 9.39% YTD vs SPYâs 1.08% as Dividend Aristocrats rebound in 2026.",
    "url": "https://finnhub.io/api/news?id=c0fc60f021ba8668f89aa3a46f7b3fd9afaf3313c8e3b9b8155c6a4d110db360",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772194865,
      "headline": "Best Dividend Aristocrats For March 2026",
      "id": 139252799,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2209914068/image_2209914068.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "NOBL is up 9.39% YTD vs SPYâs 1.08% as Dividend Aristocrats rebound in 2026.",
      "url": "https://finnhub.io/api/news?id=c0fc60f021ba8668f89aa3a46f7b3fd9afaf3313c8e3b9b8155c6a4d110db360"
    }
  },
  {
    "ts": null,
    "headline": "3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR",
    "summary": "The 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. Throughout the period, these three releases have stood out.",
    "url": "https://finnhub.io/api/news?id=114596c051f55879d74d8632085c1005bb02d1fd1fa4f9dc03a5d4138b172faa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772154240,
      "headline": "3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR",
      "id": 139242833,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "The 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. Throughout the period, these three releases have stood out.",
      "url": "https://finnhub.io/api/news?id=114596c051f55879d74d8632085c1005bb02d1fd1fa4f9dc03a5d4138b172faa"
    }
  }
]